Sustainable implementation of antibiotic stewardship on a surgical intensive care unit evaluated over a 10-year period
Related Experiment Video
Updated: Jan 3, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Stefan Schröder1, Marie-Kathrin Klein2,3, Bernhard Heising3
1Department of Anesthesiology and Intensive Care Medicine, Düren Hospital, Roonstraße 30, 52351, Düren, Germany. stefan.schroeder@krankenhaus-dueren.de.
Objective:
This retrospective observational study examined the implementation of antibiotic stewardship (ABS) on the surgical intensive care unit (SICU) of a specialized academic teaching hospital.
Methods:
Application density of antimicrobial agents (ADA), substance class change, development of resistance, and clinical outcomes were investigated with reference to ABS in three intervals over a 10-year period: the pre-intervention phase (2008-2010), the intervention phase (2011-2014), and the post-intervention phase (2015-2017).
Results:
Following the introduction of ABS, ADA was reduced from 89.3 recommended daily doses/100 patient days (RDD/100 PD) at the pre-intervention phase to 68.0 RDD/100 PD at the post-intervention phase. The antibiotic ADA (AB-ADA) similarly showed a significant decrease from 83.3 to 62.0 RDD/100 PD (p < 0.0001). The case mix index (CMI), which describes the average case severity across patients and mortality on the SICU was not significantly different comparing intervention and post-intervention phase. It was also possible to achieve a substance class change following the introduction of ABS. There was no obvious change in bacterial resistance rates.
Conclusion:
The study demonstrates a sustainable effect of the implementation of ABS, which was sustained through the post-intervention phase.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
06:18A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Urine Studies II: Urine Culture and Sensitivity Test
Antimicrobial Effectiveness
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Antibiotic Selection
Endocarditis III: Medical Management